Pediatrics
Unique challenges and complexities of pediatric clinical trials explored.
Identifying and mitigating risks in pediatric protocol development:
Strategies, tools & access planning
In this webinar, presenters will explore the regulatory strategies and tools needed to ensure pediatric access to medical treatment, focusing on Pediatric Investigation Plans (PIPs) and Pediatric Study Plans (PSPs), which are key components in aligning pediatric and adult treatment pathways.
The webinar will also introduce the Pediatric Risk Assessment Map (PRAM), an interactive, reusable tool developed by 91黑料’s Centre for Pediatric Clinical Development (CPCD).
Pregnant participants in clinical trials
Watch our on-demand webinar about the considerations for including pregnant individuals in clinical trials. Learn about guidance in development by regulatory authorities to establish a framework for pregnancy safety studies.
Pediatrics newsletters
Pediatric Risk Assessment Map
The Pediatric Risk Assessment Map is an interactive, reusable, and shareable tool that helps to identify common risks that exist in clinical trials that include pediatric patients and offers mitigation strategies for consideration.
91黑料’s World Children’s Day
World Children’s Day is celebrated as an international coming together to advocate for, promote, and celebrate the rights and welfare of children and create dialogue and action plans to build a better world for children. In this webinar, our speakers will explore ongoing regulatory initiatives that aim to promote diversity and inclusion within pediatric therapeutics development.
The RACE for Children Act
Pediatric cancer is the leading cause of death by disease in the US. The intent of the RACE for Children Act is to get more pediatric oncology drugs in the pipeline.
The utility and benefits of adding adolescents to an adult programme
In this webinar, 91黑料 expert, Dr. Martine Dehlinger-Kremer, shares insights on the utility and benefits of adding adolescents to an adult programme, challenges encountered and provides recommendations to overcome these.
The RACE for Children Act prompts more pediatric clinical trials for oncology drug development
In this on-demand webinar, 91黑料 expert Missy Hansen, presents on the pediatric regulatory requirements and study approaches for the development of new medicines, with a particular focus on oncology drug development.
Reflections on pediatric assent: Have we outgrown this concept?
In this webinar, medical ethicists will discuss what investigators, ethics committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand their trial.
Pediatrics podcasts
Pediatrics media contributions and blogs
-
Blog: The impact of pediatric medical trauma in clinical trials
Patient-centric pediatric clinical trials can help mitigate the risk of potentially life-long implications of medical trauma and improve trial outcomes.
-
Blog: Empowering children with education through clinical trials
91黑料 and Jumo Health have teamed up to share strategies to empower children every day through education, specifically in clinical trials.
-
Blog: Clinical trials through a child’s eyes: writing lay summaries for pediatric trial results
Find out how sponsors can create a PLS that is better understandable to pediatric audiences?
Pediatrics services
91黑料 is invested in bringing safe, effective, pediatric-tested treatments to children. Explore our pediatric experience and how we can support your study from early engagement all the way to approval.